These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 36441274)

  • 1. Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis.
    Kleinert S; Schuch F; Rapp P; Ronneberger M; Wendler J; Sternad P; Popp F; Bartz-Bazzanella P; von der Decken C; Karberg K; Gauler G; Wurth P; Späthling-Mestekemper S; Kuhn C; Englbrecht M; Vorbrüggen W; Adler G; Welcker M
    Rheumatol Int; 2023 Jan; 43(1):89-97. PubMed ID: 36441274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry.
    Ciurea A; Götschi A; Kissling S; Bernatschek A; Bürki K; Exer P; Nissen MJ; Möller B; Scherer A; Micheroli R
    RMD Open; 2023 Jun; 9(2):. PubMed ID: 37277211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriatic Spondylitis: A Disease Manifestation in Debate: Evidences to Know for the Clinical Rheumatologist.
    Zeidler HK
    J Clin Rheumatol; 2022 Jan; 28(1):38-43. PubMed ID: 34941618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep behaviour differs in women and men with psoriatic arthritis and axial spondyloarthritis with impact on quality of life and depressive symptoms.
    Frede N; Rieger E; Lorenzetti R; Venhoff AC; Kanne AM; Finzel S; Jandova I; Glaser C; Thiel J; Voll RE; Venhoff N
    RMD Open; 2023 May; 9(2):. PubMed ID: 37208029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using natural language processing to explore characteristics and management of patients with axial spondyloarthritis and psoriatic arthritis treated under real-world conditions in Spain: SpAINET study.
    Benavent D; Muñoz-Fernández S; De la Morena I; Fernández-Nebro A; Marín-Corral J; Castillo Rosa E; Taberna M; Sanabra C; Sastre C;
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X231220818. PubMed ID: 38146537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in axial spondyloarthritis diagnoses after the introduction of the ASAS criteria: a systematic review.
    Jamal M; van Delft ETAM; den Braanker H; Kuijper TM; Hazes JMW; Lopes Barreto D; Weel AEAM
    Rheumatol Int; 2023 Apr; 43(4):639-649. PubMed ID: 36637486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raftlin - a potential biomarker for axial spondyloarthritis and psoriatic arthritis: An observational study.
    Yurdakul OV; Kara M; Ince B; Yildiz C; Yildiz T; Kilicoglu MS; Aydin T; Ozer OF
    Medicine (Baltimore); 2024 Jun; 103(26):e38770. PubMed ID: 38941376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Men and Women With Axial Spondyloarthritis in the US-based Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
    Mease PJ; McLean RR; Dube B; Liu M; Rebello S; Glynn M; Yi E; Park Y; Ogdie A
    J Rheumatol; 2021 Oct; 48(10):1528-1536. PubMed ID: 33858974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
    Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
    Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
    Kaplan H; Cengiz G; Şaş S; Eldemir YÖ
    Clin Rheumatol; 2023 Nov; 42(11):2959-2969. PubMed ID: 37470884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study.
    Benavent D; Plasencia C; Poddubnyy D; Kishimoto M; Proft F; Sawada H; López-Medina C; Dougados M; Navarro-Compán V
    Semin Arthritis Rheum; 2021 Aug; 51(4):766-774. PubMed ID: 34144387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study.
    Benavent D; Capelusnik D; Ramiro S; Molto A; López-Medina C; Dougados M; Navarro-Compán V
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36096523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher frequency but similar recurrence rate of uveitis episodes in axial spondylarthritis compared to psoriatic arthritis. A multicentre retrospective study.
    Kougkas N; Magiouf K; Gialouri CG; Evangelatos G; Pappa M; Dimouli A; Iliopoulos A; Karmanakos A; Dimitroulas T; Tektonidou MG; Sfikakis PP; Fragoulis GE
    Rheumatol Int; 2023 Nov; 43(11):2081-2088. PubMed ID: 37610650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.
    Deodhar A; Blauvelt A; Lebwohl M; Feely M; Kronbergs A; Eberhart N; Zhu D; Inman E; Grace E; Holzkaemper T; Rahman P; Marzo-Ortega H; Papp KA; Merola JF; Gottlieb AB; Schwartzman S
    Arthritis Res Ther; 2024 Feb; 26(1):49. PubMed ID: 38347650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered sleep in axial spondyloarthritis and psoriatic arthritis: Post hoc comparative study based on a sleep-specific question from the ASAS health index.
    Alonso S; Morante I; Braña I; Queiro R
    Reumatol Clin (Engl Ed); 2023 Oct; 19(8):430-435. PubMed ID: 37805256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.
    Feist E; Baraliakos X; Behrens F; Thaçi D; Plenske A; Klaus P; Meng T
    Rheumatol Ther; 2024 Apr; 11(2):331-348. PubMed ID: 38308727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts.
    de Hooge M; Ishchenko A; De Craemer AS; Steinfeld S; Nzeusseu A; Elewaut D; Lories R; de Vlam K; Van den Bosch F
    RMD Open; 2023 May; 9(2):. PubMed ID: 37137541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.
    Regierer AC; Weiß A; Proft F; Baraliakos X; Behrens F; Poddubnyy D; Schett G; Lorenz HM; Worsch M; Strangfeld A
    RMD Open; 2023 Mar; 9(1):. PubMed ID: 36898762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depression/anxiety symptoms in axial spondyloarthritis and psoriatic arthritis patients in Serbia: a pilot study.
    Milutinovic S; Veljkovic K; Zlatanovic M; Radunovic G; Damjanov N
    Rheumatol Int; 2019 Sep; 39(9):1595-1605. PubMed ID: 31309294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Residual Disease Burden in Patients With Axial Spondyloarthritis and Psoriatic Arthritis Despite Low Disease Activity States in a Multiethnic Asian Population.
    Liu V; Fong W; Kwan YH; Leung YY
    J Rheumatol; 2021 May; 48(5):677-684. PubMed ID: 33132217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.